Industry Research Reports

Home > Reports > Service & Software > Global Preclinical Contract Research Organization (CRO) Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Preclinical Contract Research Organization (CRO) Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Service & Software

Published Date: 2025-11-16

Pages: 138 Pages

Report ld: 5451296

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Preclinical Contract Research Organization (CRO) Market Size(US$)

CAGR 2025-2031

8.2%

Market Size,2031

USD 31,040

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 19,380 million

Market Forecast in 2031(Value)

US$ 31,040 million

CAGR

8.2%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Preclinical Contract Research Organization (CRO) market is projected to grow from US$ 17780 million in 2024 to US$ 31040 million by 2031, at a CAGR of 8.2% (2025-2031), driven by critical product segments and diverse end‑use applications.

A Preclinical Contract Research Organization (CRO) is a specialized service provider that offers research and development services to pharmaceutical, biotechnology, and medical device companies during the preclinical stages of drug development. Preclinical CROs conduct a wide range of studies, including in vitro and in vivo testing, toxicology studies, pharmacokinetics assessments, and other preclinical research activities to evaluate the safety, efficacy, and pharmacological profiles of potential drug candidates before they advance to clinical trials.ical trials (or receiving other approvals like 510Ks) or use for human care.

Market Drivers for Preclinical Contract Research Organization (CRO):

Outsourcing Trends in Drug Development: Pharmaceutical and biotechnology companies are increasingly outsourcing preclinical research activities to specialized CROs to leverage their expertise, infrastructure, and capabilities, enabling cost savings and operational efficiencies.

Focus on Specialized Expertise: Preclinical CROs offer specialized scientific knowledge, technical skills, and state-of-the-art facilities that cater to the specific requirements of preclinical research, allowing sponsor companies to access specialized expertise without the need for in-house capabilities.

Demand for Accelerated Drug Development: The need for faster time-to-market and efficient drug development processes is driving the demand for preclinical CRO services, as these organizations can streamline preclinical studies, optimize workflows, and expedite the drug development timeline.

Increasing Complexity of Drug Discovery: The growing complexity of drug targets, therapeutic modalities, and regulatory requirements in drug discovery necessitates the expertise and resources offered by preclinical CROs to conduct comprehensive preclinical assessments and address scientific challenges.

Globalization of Clinical Trials: The globalization of clinical trials and the need for diverse patient populations for testing novel therapies require preclinical CROs with a global presence and capabilities to conduct studies in various regions, ensuring regulatory compliance and access to diverse resources.

Market Challenges for Preclinical Contract Research Organization (CRO):

Regulatory Compliance and Quality Assurance: Preclinical CROs must adhere to stringent regulatory guidelines, Good Laboratory Practice (GLP) standards, and quality assurance requirements to ensure the validity, integrity, and reliability of preclinical study data, posing challenges in maintaining compliance and documentation.

Competitive Landscape and Differentiation: The competitive landscape in the preclinical CRO industry is evolving, with increasing competition among service providers, necessitating differentiation through innovative services, technology investments, and strategic partnerships to stand out in the market.

Data Integration and Interpretation: Managing and integrating large volumes of preclinical data generated from diverse studies and assays can be challenging, requiring advanced data analytics, bioinformatics tools, and expertise in data interpretation to derive meaningful insights for clients.

Technological Advancements and Infrastructure Investments: Keeping pace with rapid technological advancements in preclinical research, such as advanced imaging techniques, high-throughput screening platforms, and molecular analysis tools, requires continuous investment in infrastructure, equipment, and staff training.

Risk Management and Project Timelines: Managing project timelines, mitigating risks, and ensuring the successful completion of preclinical studies within specified deadlines impose challenges on preclinical CROs, necessitating effective project management, communication, and contingency planning.

Report Includes:

This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Preclinical Contract Research Organization (CRO) market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

Wuxi AppTec
Charles River
Labcorp
Eurofins Scientific
PPD, Inc.
ICON Plc.
Pharmaron
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Crown Bioscience
Champion Oncology

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Bioanalysis and DMPK Studies
Toxicology Testing
Safety Pharmacology
Others

Segment by Application

Pharmaceutical Companies
Medical Device Companies
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the Preclinical Contract Research Organization (CRO) study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.

Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.

Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.

Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.

Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.

Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles

Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.

Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.

Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 14: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Introduction to Preclinical Contract Research Organization (CRO): Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Preclinical Contract Research Organization (CRO) Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Bioanalysis and DMPK Studies

1.2.3 Toxicology Testing

1.2.4 Safety Pharmacology

1.2.5 Others

1.3 Market Segmentation by Application

1.3.1 Global Preclinical Contract Research Organization (CRO) Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical Companies

1.3.3 Medical Device Companies

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Preclinical Contract Research Organization (CRO) Revenue Estimates and Forecasts 2020-2031

2.2 Global Preclinical Contract Research Organization (CRO) Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020-2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competition by Players

3.1 Global Preclinical Contract Research Organization (CRO) Player Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2020-2025)

3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Player (2020 VS 2024)

3.2 Global Preclinical Contract Research Organization (CRO) Companies Headquarters and Service Footprint

3.3 Main Product Type Market Size by Players

3.3.1 Bioanalysis and DMPK Studies Market Size by Players

3.3.2 Toxicology Testing Market Size by Players

3.3.3 Safety Pharmacology Market Size by Players

3.3.4 Others Market Size by Players

3.4 Global Preclinical Contract Research Organization (CRO) Market Concentration and Dynamics

3.4.1 Global Market Concentration (CR5 and HHI)

3.4.2 Entrant/Exit Impact Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Preclinical Contract Research Organization (CRO) Revenue Trends by Type

4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.1.2 Global Revenue Market Share by Type (2020-2031)

4.2 Key Product Attributes and Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Preclinical Contract Research Organization (CRO) Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.1.2 Revenue Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

6 North America

6.1 North America Market Size (2020-2031)

6.2 North America Key Players Revenue in 2024

6.3 North America Preclinical Contract Research Organization (CRO) Market Size by Type (2020-2031)

6.4 North America Preclinical Contract Research Organization (CRO) Market Size by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Preclinical Contract Research Organization (CRO) Market Size by Country

6.6.1 North America Revenue Trends by Country

6.6.2 US

6.6.3 Canada

6.6.4 Mexico

7 Europe

7.1 Europe Market Size (2020-2031)

7.2 Europe Key Players Revenue in 2024

7.3 Europe Preclinical Contract Research Organization (CRO) Market Size by Type (2020-2031)

7.4 Europe Preclinical Contract Research Organization (CRO) Market Size by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Preclinical Contract Research Organization (CRO) Market Size by Country

7.6.1 Europe Revenue Trends by Country

7.6.2 Germany

7.6.3 France

7.6.4 U.K.

7.6.5 Italy

7.6.6 Russia

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2020-2031)

8.2 Asia-Pacific Key Players Revenue in 2024

8.3 Asia-Pacific Preclinical Contract Research Organization (CRO) Market Size by Type (2020-2031)

8.4 Asia-Pacific Preclinical Contract Research Organization (CRO) Market Size by Application (2020-2031)

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Asia-Pacific Preclinical Contract Research Organization (CRO) Market Size by Region

8.6.1 Asia-Pacific Revenue Trends by Region

8.7 China

8.8 Japan

8.9 South Korea

8.10 Australia

8.11 India

8.12 Southeast Asia

8.12.1 Indonesia

8.12.2 Vietnam

8.12.3 Malaysia

8.12.4 Philippines

8.12.5 Singapore

9 Central and South America

9.1 Central and South America Market Size (2020-2031)

9.2 Central and South America Key Players Revenue in 2024

9.3 Central and South America Preclinical Contract Research Organization (CRO) Market Size by Type (2020-2031)

9.4 Central and South America Preclinical Contract Research Organization (CRO) Market Size by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Preclinical Contract Research Organization (CRO) Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2020-2031)

10.2 Middle East and Africa Key Players Revenue in 2024

10.3 Middle East and Africa Preclinical Contract Research Organization (CRO) Market Size by Type (2020-2031)

10.4 Middle East and Africa Preclinical Contract Research Organization (CRO) Market Size by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Preclinical Contract Research Organization (CRO) Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Israel

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Wuxi AppTec

11.1.1 Wuxi AppTec Corporation Information

11.1.2 Wuxi AppTec Business Overview

11.1.3 Wuxi AppTec Preclinical Contract Research Organization (CRO) Product Features and Attributes

11.1.4 Wuxi AppTec Preclinical Contract Research Organization (CRO) Revenue and Gross Margin (2020-2025)

11.1.5 Wuxi AppTec Preclinical Contract Research Organization (CRO) Revenue by Product in 2024

11.1.6 Wuxi AppTec Preclinical Contract Research Organization (CRO) Revenue by Application in 2024

11.1.7 Wuxi AppTec Preclinical Contract Research Organization (CRO) Revenue by Geographic Area in 2024

11.1.8 Wuxi AppTec Preclinical Contract Research Organization (CRO) SWOT Analysis

11.1.9 Wuxi AppTec Recent Developments

11.2 Charles River

11.2.1 Charles River Corporation Information

11.2.2 Charles River Business Overview

11.2.3 Charles River Preclinical Contract Research Organization (CRO) Product Features and Attributes

11.2.4 Charles River Preclinical Contract Research Organization (CRO) Revenue and Gross Margin (2020-2025)

11.2.5 Charles River Preclinical Contract Research Organization (CRO) Revenue by Product in 2024

11.2.6 Charles River Preclinical Contract Research Organization (CRO) Revenue by Application in 2024

11.2.7 Charles River Preclinical Contract Research Organization (CRO) Revenue by Geographic Area in 2024

11.2.8 Charles River Preclinical Contract Research Organization (CRO) SWOT Analysis

11.2.9 Charles River Recent Developments

11.3 Labcorp

11.3.1 Labcorp Corporation Information

11.3.2 Labcorp Business Overview

11.3.3 Labcorp Preclinical Contract Research Organization (CRO) Product Features and Attributes

11.3.4 Labcorp Preclinical Contract Research Organization (CRO) Revenue and Gross Margin (2020-2025)

11.3.5 Labcorp Preclinical Contract Research Organization (CRO) Revenue by Product in 2024

11.3.6 Labcorp Preclinical Contract Research Organization (CRO) Revenue by Application in 2024

11.3.7 Labcorp Preclinical Contract Research Organization (CRO) Revenue by Geographic Area in 2024

11.3.8 Labcorp Preclinical Contract Research Organization (CRO) SWOT Analysis

11.3.9 Labcorp Recent Developments

11.4 Eurofins Scientific

11.4.1 Eurofins Scientific Corporation Information

11.4.2 Eurofins Scientific Business Overview

11.4.3 Eurofins Scientific Preclinical Contract Research Organization (CRO) Product Features and Attributes

11.4.4 Eurofins Scientific Preclinical Contract Research Organization (CRO) Revenue and Gross Margin (2020-2025)

11.4.5 Eurofins Scientific Preclinical Contract Research Organization (CRO) Revenue by Product in 2024

11.4.6 Eurofins Scientific Preclinical Contract Research Organization (CRO) Revenue by Application in 2024

11.4.7 Eurofins Scientific Preclinical Contract Research Organization (CRO) Revenue by Geographic Area in 2024

11.4.8 Eurofins Scientific Preclinical Contract Research Organization (CRO) SWOT Analysis

11.4.9 Eurofins Scientific Recent Developments

11.5 PPD, Inc.

11.5.1 PPD, Inc. Corporation Information

11.5.2 PPD, Inc. Business Overview

11.5.3 PPD, Inc. Preclinical Contract Research Organization (CRO) Product Features and Attributes

11.5.4 PPD, Inc. Preclinical Contract Research Organization (CRO) Revenue and Gross Margin (2020-2025)

11.5.5 PPD, Inc. Preclinical Contract Research Organization (CRO) Revenue by Product in 2024

11.5.6 PPD, Inc. Preclinical Contract Research Organization (CRO) Revenue by Application in 2024

11.5.7 PPD, Inc. Preclinical Contract Research Organization (CRO) Revenue by Geographic Area in 2024

11.5.8 PPD, Inc. Preclinical Contract Research Organization (CRO) SWOT Analysis

11.5.9 PPD, Inc. Recent Developments

11.6 ICON Plc.

11.6.1 ICON Plc. Corporation Information

11.6.2 ICON Plc. Business Overview

11.6.3 ICON Plc. Preclinical Contract Research Organization (CRO) Product Features and Attributes

11.6.4 ICON Plc. Preclinical Contract Research Organization (CRO) Revenue and Gross Margin (2020-2025)

11.6.5 ICON Plc. Recent Developments

11.7 Pharmaron

11.7.1 Pharmaron Corporation Information

11.7.2 Pharmaron Business Overview

11.7.3 Pharmaron Preclinical Contract Research Organization (CRO) Product Features and Attributes

11.7.4 Pharmaron Preclinical Contract Research Organization (CRO) Revenue and Gross Margin (2020-2025)

11.7.5 Pharmaron Recent Developments

11.8 Inotiv

11.8.1 Inotiv Corporation Information

11.8.2 Inotiv Business Overview

11.8.3 Inotiv Preclinical Contract Research Organization (CRO) Product Features and Attributes

11.8.4 Inotiv Preclinical Contract Research Organization (CRO) Revenue and Gross Margin (2020-2025)

11.8.5 Inotiv Recent Developments

11.9 ChemPartner

11.9.1 ChemPartner Corporation Information

11.9.2 ChemPartner Business Overview

11.9.3 ChemPartner Preclinical Contract Research Organization (CRO) Product Features and Attributes

11.9.4 ChemPartner Preclinical Contract Research Organization (CRO) Revenue and Gross Margin (2020-2025)

11.9.5 ChemPartner Recent Developments

11.10 JOINN Lab

11.10.1 JOINN Lab Corporation Information

11.10.2 JOINN Lab Business Overview

11.10.3 JOINN Lab Preclinical Contract Research Organization (CRO) Product Features and Attributes

11.10.4 JOINN Lab Preclinical Contract Research Organization (CRO) Revenue and Gross Margin (2020-2025)

11.10.5 Company Ten Recent Developments

11.11 EVOTEC

11.11.1 EVOTEC Corporation Information

11.11.2 EVOTEC Business Overview

11.11.3 EVOTEC Preclinical Contract Research Organization (CRO) Product Features and Attributes

11.11.4 EVOTEC Preclinical Contract Research Organization (CRO) Revenue and Gross Margin (2020-2025)

11.11.5 EVOTEC Recent Developments

11.12 Medicilon

11.12.1 Medicilon Corporation Information

11.12.2 Medicilon Business Overview

11.12.3 Medicilon Preclinical Contract Research Organization (CRO) Product Features and Attributes

11.12.4 Medicilon Preclinical Contract Research Organization (CRO) Revenue and Gross Margin (2020-2025)

11.12.5 Medicilon Recent Developments

11.13 Crown Bioscience

11.13.1 Crown Bioscience Corporation Information

11.13.2 Crown Bioscience Business Overview

11.13.3 Crown Bioscience Preclinical Contract Research Organization (CRO) Product Features and Attributes

11.13.4 Crown Bioscience Preclinical Contract Research Organization (CRO) Revenue and Gross Margin (2020-2025)

11.13.5 Crown Bioscience Recent Developments

11.14 Champion Oncology

11.14.1 Champion Oncology Corporation Information

11.14.2 Champion Oncology Business Overview

11.14.3 Champion Oncology Preclinical Contract Research Organization (CRO) Product Features and Attributes

11.14.4 Champion Oncology Preclinical Contract Research Organization (CRO) Revenue and Gross Margin (2020-2025)

11.14.5 Champion Oncology Recent Developments

12 Preclinical Contract Research Organization (CRO)Industry Chain Analysis

12.1 Preclinical Contract Research Organization (CRO) Industry Chain

12.2 Upstream Analysis

12.2.1 Upstream Key Suppliers

12.3 Middlestream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Preclinical Contract Research Organization (CRO) Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Preclinical Contract Research Organization (CRO) Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Preclinical Contract Research Organization (CRO) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Preclinical Contract Research Organization (CRO) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Preclinical Contract Research Organization (CRO) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Preclinical Contract Research Organization (CRO) Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Preclinical Contract Research Organization (CRO) Revenue by Region (2026-2031) & (US$ Million)

Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 7. Global Preclinical Contract Research Organization (CRO) Revenue by Players (2020-2025) & (US$ Million)

Table 8. Global Preclinical Contract Research Organization (CRO) Revenue Market Share by Players (2020-2025)

Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 10. Global Preclinical Contract Research Organization (CRO) by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical Contract Research Organization (CRO) as of 2024)

Table 11. Global Preclinical Contract Research Organization (CRO) Average Gross Margin (%) by Player (2020 VS 2024)

Table 12. Global Preclinical Contract Research Organization (CRO) Companies Headquarters

Table 13. Global Preclinical Contract Research Organization (CRO) Market Concentration Ratio (CR5 and HHI)

Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 16. Global Preclinical Contract Research Organization (CRO) Revenue by Type (2020-2025) & (US$ Million)

Table 17. Global Preclinical Contract Research Organization (CRO) Revenue by Type (2026-2031) & (US$ Million)

Table 18. Key Product Attributes and Differentiation

Table 19. Global Preclinical Contract Research Organization (CRO) Revenue by Application (2020-2025) & (US$ Million)

Table 20. Global Preclinical Contract Research Organization (CRO) Revenue by Application (2026-2031) & (US$ Million)

Table 21. Preclinical Contract Research Organization (CRO) High-Growth Sectors Demand CAGR (2024-2031)

Table 22. Top Customers by Region

Table 23. Top Customers by Application

Table 24. North America Preclinical Contract Research Organization (CRO) Growth Accelerators and Market Barriers

Table 25. North America Preclinical Contract Research Organization (CRO) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 26. Europe Preclinical Contract Research Organization (CRO) Growth Accelerators and Market Barriers

Table 27. Europe Preclinical Contract Research Organization (CRO) Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 28. Asia-Pacific Preclinical Contract Research Organization (CRO) Growth Accelerators and Market Barriers

Table 29. Asia-Pacific Preclinical Contract Research Organization (CRO) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 30. Central and South America Preclinical Contract Research Organization (CRO) Investment Opportunities and Key Challenges

Table 31. Central and South America Preclinical Contract Research Organization (CRO) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 32. Middle East and Africa Preclinical Contract Research Organization (CRO) Investment Opportunities and Key Challenges

Table 33. Middle East and Africa Preclinical Contract Research Organization (CRO) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 34. Wuxi AppTec Corporation Information

Table 35. Wuxi AppTec Description and Major Businesses

Table 36. Wuxi AppTec Product Features and Attributes

Table 37. Wuxi AppTec Revenue (US$ Million) and Gross Margin (2020-2025)

Table 38. Wuxi AppTec Revenue Proportion by Product in 2024

Table 39. Wuxi AppTec Revenue Proportion by Application in 2024

Table 40. Wuxi AppTec Revenue Proportion by Geographic Area in 2024

Table 41. Wuxi AppTec Preclinical Contract Research Organization (CRO) SWOT Analysis

Table 42. Wuxi AppTec Recent Developments

Table 43. Charles River Corporation Information

Table 44. Charles River Description and Major Businesses

Table 45. Charles River Product Features and Attributes

Table 46. Charles River Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. Charles River Revenue Proportion by Product in 2024

Table 48. Charles River Revenue Proportion by Application in 2024

Table 49. Charles River Revenue Proportion by Geographic Area in 2024

Table 50. Charles River Preclinical Contract Research Organization (CRO) SWOT Analysis

Table 51. Charles River Recent Developments

Table 52. Labcorp Corporation Information

Table 53. Labcorp Description and Major Businesses

Table 54. Labcorp Product Features and Attributes

Table 55. Labcorp Revenue (US$ Million) and Gross Margin (2020-2025)

Table 56. Labcorp Revenue Proportion by Product in 2024

Table 57. Labcorp Revenue Proportion by Application in 2024

Table 58. Labcorp Revenue Proportion by Geographic Area in 2024

Table 59. Labcorp Preclinical Contract Research Organization (CRO) SWOT Analysis

Table 60. Labcorp Recent Developments

Table 61. Eurofins Scientific Corporation Information

Table 62. Eurofins Scientific Description and Major Businesses

Table 63. Eurofins Scientific Product Features and Attributes

Table 64. Eurofins Scientific Revenue (US$ Million) and Gross Margin (2020-2025)

Table 65. Eurofins Scientific Revenue Proportion by Product in 2024

Table 66. Eurofins Scientific Revenue Proportion by Application in 2024

Table 67. Eurofins Scientific Revenue Proportion by Geographic Area in 2024

Table 68. Eurofins Scientific Preclinical Contract Research Organization (CRO) SWOT Analysis

Table 69. Eurofins Scientific Recent Developments

Table 70. PPD, Inc. Corporation Information

Table 71. PPD, Inc. Description and Major Businesses

Table 72. PPD, Inc. Product Features and Attributes

Table 73. PPD, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)

Table 74. PPD, Inc. Revenue Proportion by Product in 2024

Table 75. PPD, Inc. Revenue Proportion by Application in 2024

Table 76. PPD, Inc. Revenue Proportion by Geographic Area in 2024

Table 77. PPD, Inc. Preclinical Contract Research Organization (CRO) SWOT Analysis

Table 78. PPD, Inc. Recent Developments

Table 79. ICON Plc. Corporation Information

Table 80. ICON Plc. Description and Major Businesses

Table 81. ICON Plc. Product Features and Attributes

Table 82. ICON Plc. Revenue (US$ Million) and Gross Margin (2020-2025)

Table 83. ICON Plc. Recent Developments

Table 84. Pharmaron Corporation Information

Table 85. Pharmaron Description and Major Businesses

Table 86. Pharmaron Product Features and Attributes

Table 87. Pharmaron Revenue (US$ Million) and Gross Margin (2020-2025)

Table 88. Pharmaron Recent Developments

Table 89. Inotiv Corporation Information

Table 90. Inotiv Description and Major Businesses

Table 91. Inotiv Product Features and Attributes

Table 92. Inotiv Revenue (US$ Million) and Gross Margin (2020-2025)

Table 93. Inotiv Recent Developments

Table 94. ChemPartner Corporation Information

Table 95. ChemPartner Description and Major Businesses

Table 96. ChemPartner Product Features and Attributes

Table 97. ChemPartner Revenue (US$ Million) and Gross Margin (2020-2025)

Table 98. ChemPartner Recent Developments

Table 99. JOINN Lab Corporation Information

Table 100. JOINN Lab Description and Major Businesses

Table 101. JOINN Lab Product Features and Attributes

Table 102. JOINN Lab Revenue (US$ Million) and Gross Margin (2020-2025)

Table 103. JOINN Lab Recent Developments

Table 104. EVOTEC Corporation Information

Table 105. EVOTEC Description and Major Businesses

Table 106. EVOTEC Product Features and Attributes

Table 107. EVOTEC Revenue (US$ Million) and Gross Margin (2020-2025)

Table 108. EVOTEC Recent Developments

Table 109. Medicilon Corporation Information

Table 110. Medicilon Description and Major Businesses

Table 111. Medicilon Product Features and Attributes

Table 112. Medicilon Revenue (US$ Million) and Gross Margin (2020-2025)

Table 113. Medicilon Recent Developments

Table 114. Crown Bioscience Corporation Information

Table 115. Crown Bioscience Description and Major Businesses

Table 116. Crown Bioscience Product Features and Attributes

Table 117. Crown Bioscience Revenue (US$ Million) and Gross Margin (2020-2025)

Table 118. Crown Bioscience Recent Developments

Table 119. Champion Oncology Corporation Information

Table 120. Champion Oncology Description and Major Businesses

Table 121. Champion Oncology Product Features and Attributes

Table 122. Champion Oncology Revenue (US$ Million) and Gross Margin (2020-2025)

Table 123. Champion Oncology Recent Developments

Table 124. Raw Materials Key Suppliers

Table 125. Distributors List

Table 126. Market Trends and Market Evolution

Table 127. Market Drivers and Opportunities

Table 128. Market Challenges, Risks, and Restraints

Table 129. Research Programs/Design for This Report

Table 130. Key Data Information from Secondary Sources

Table 131. Key Data Information from Primary Sources

List of Figures

Figure 1. Preclinical Contract Research Organization (CRO) Product Picture

Figure 2. Global Preclinical Contract Research Organization (CRO) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Bioanalysis and DMPK Studies Product Picture

Figure 4. Toxicology Testing Product Picture

Figure 5. Safety Pharmacology Product Picture

Figure 6. Others Product Picture

Figure 7. Global Preclinical Contract Research Organization (CRO) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 8. Pharmaceutical Companies

Figure 9. Medical Device Companies

Figure 10. Others

Figure 11. Preclinical Contract Research Organization (CRO) Report Years Considered

Figure 12. Global Preclinical Contract Research Organization (CRO) Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Preclinical Contract Research Organization (CRO) Revenue (2020-2031) & (US$ Million)

Figure 14. Global Preclinical Contract Research Organization (CRO) Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 15. Global Preclinical Contract Research Organization (CRO) Revenue Market Share by Region (2020-2031)

Figure 16. Global Preclinical Contract Research Organization (CRO) Revenue Market Share Ranking (2024)

Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 18. Bioanalysis and DMPK Studies Revenue Market Share by Player in 2024

Figure 19. Toxicology Testing Revenue Market Share by Player in 2024

Figure 20. Safety Pharmacology Revenue Market Share by Player in 2024

Figure 21. Others Revenue Market Share by Player in 2024

Figure 22. Global Preclinical Contract Research Organization (CRO) Revenue Market Share by Type (2020-2031)

Figure 23. Global Preclinical Contract Research Organization (CRO) Revenue Market Share by Application (2020-2031)

Figure 24. North America Preclinical Contract Research Organization (CRO) Revenue YoY (2020-2031) & (US$ Million)

Figure 25. North America Top 5 Players Preclinical Contract Research Organization (CRO) Revenue (US$ Million) in 2024

Figure 26. North America Preclinical Contract Research Organization (CRO) Revenue (US$ Million) by Type (2020 - 2031)

Figure 27. North America Preclinical Contract Research Organization (CRO) Revenue (US$ Million) by Application (2020-2031)

Figure 28. US Preclinical Contract Research Organization (CRO) Revenue (2020-2031) & (US$ Million)

Figure 29. Canada Preclinical Contract Research Organization (CRO) Revenue (2020-2031) & (US$ Million)

Figure 30. Mexico Preclinical Contract Research Organization (CRO) Revenue (2020-2031) & (US$ Million)

Figure 31. Europe Preclinical Contract Research Organization (CRO) Revenue YoY (2020-2031) & (US$ Million)

Figure 32. Europe Top 5 Players Preclinical Contract Research Organization (CRO) Revenue (US$ Million) in 2024

Figure 33. Europe Preclinical Contract Research Organization (CRO) Revenue (US$ Million) by Type (2020-2031)

Figure 34. Europe Preclinical Contract Research Organization (CRO) Revenue (US$ Million) by Application (2020-2031)

Figure 35. Germany Preclinical Contract Research Organization (CRO) Revenue (2020-2031) & (US$ Million)

Figure 36. France Preclinical Contract Research Organization (CRO) Revenue (2020-2031) & (US$ Million)

Figure 37. U.K. Preclinical Contract Research Organization (CRO) Revenue (2020-2031) & (US$ Million)

Figure 38. Italy Preclinical Contract Research Organization (CRO) Revenue (2020-2031) & (US$ Million)

Figure 39. Russia Preclinical Contract Research Organization (CRO) Revenue (2020-2031) & (US$ Million)

Figure 40. Asia-Pacific Preclinical Contract Research Organization (CRO) Revenue YoY (2020-2031) & (US$ Million)

Figure 41. Asia-Pacific Top 8 Players Preclinical Contract Research Organization (CRO) Revenue (US$ Million) in 2024

Figure 42. Asia-Pacific Preclinical Contract Research Organization (CRO) Revenue (US$ Million) by Type (2020-2031)

Figure 43. Asia-Pacific Preclinical Contract Research Organization (CRO) Revenue (US$ Million) by Application (2020-2031)

Figure 44. Indonesia Preclinical Contract Research Organization (CRO) Revenue (2020-2031) & (US$ Million)

Figure 45. Japan Preclinical Contract Research Organization (CRO) Revenue (2020-2031) & (US$ Million)

Figure 46. South Korea Preclinical Contract Research Organization (CRO) Revenue (2020-2031) & (US$ Million)

Figure 47. Australia Preclinical Contract Research Organization (CRO) Revenue (2020-2031) & (US$ Million)

Figure 48. India Preclinical Contract Research Organization (CRO) Revenue (2020-2031) & (US$ Million)

Figure 49. Indonesia Preclinical Contract Research Organization (CRO) Revenue (2020-2031) & (US$ Million)

Figure 50. Vietnam Preclinical Contract Research Organization (CRO) Revenue (2020-2031) & (US$ Million)

Figure 51. Malaysia Preclinical Contract Research Organization (CRO) Revenue (2020-2031) & (US$ Million)

Figure 52. Philippines Preclinical Contract Research Organization (CRO) Revenue (2020-2031) & (US$ Million)

Figure 53. Singapore Preclinical Contract Research Organization (CRO) Revenue (2020-2031) & (US$ Million)

Figure 54. Central and South America Preclinical Contract Research Organization (CRO) Revenue YoY (2020-2031) & (US$ Million)

Figure 55. Central and South America Top 5 Players Preclinical Contract Research Organization (CRO) Revenue (US$ Million) in 2024

Figure 56. Central and South America Preclinical Contract Research Organization (CRO) Revenue (US$ Million) by Type (2020-2031)

Figure 57. Central and South America Preclinical Contract Research Organization (CRO) Revenue (US$ Million) by Application (2020-2031)

Figure 58. Brazil Preclinical Contract Research Organization (CRO) Revenue (2020-2025) & (US$ Million)

Figure 59. Argentina Preclinical Contract Research Organization (CRO) Revenue (2020-2025) & (US$ Million)

Figure 60. Middle East and Africa Preclinical Contract Research Organization (CRO) Revenue YoY (2020-2031) & (US$ Million)

Figure 61. Middle East and Africa Top 5 Players Preclinical Contract Research Organization (CRO) Revenue (US$ Million) in 2024

Figure 62. South America Preclinical Contract Research Organization (CRO) Revenue (US$ Million) by Type (2020-2031)

Figure 63. Middle East and Africa Preclinical Contract Research Organization (CRO) Revenue (US$ Million) by Application (2020-2031)

Figure 64. GCC Countries Preclinical Contract Research Organization (CRO) Revenue (2020-2025) & (US$ Million)

Figure 65. Israel Preclinical Contract Research Organization (CRO) Revenue (2020-2025) & (US$ Million)

Figure 66. Egypt Preclinical Contract Research Organization (CRO) Revenue (2020-2025) & (US$ Million)

Figure 67. South Africa Preclinical Contract Research Organization (CRO) Revenue (2020-2025) & (US$ Million)

Figure 68. Preclinical Contract Research Organization (CRO) Industry Chain Mapping

Figure 69. Channels of Distribution (Direct Vs Distribution)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Preclinical Contract Research Organization (CRO) in 2025? zhanKai

The global market size of Preclinical Contract Research Organization (CRO) in 2025 was 19380 Million USD.

What is the annual compound growth rate of the global Preclinical Contract Research Organization (CRO) market size from 2025 to 2031? shouQi

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Preclinical Contract Research Organization (CRO) market? shouQi

What was the global market size of Preclinical Contract Research Organization (CRO) in 2031? shouQi

Related Reports

Global Preclinical Contract Research Organization (CRO) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Preclinical Contract Research Organization (CRO) market size was US$ 19380 million in 2025 and is forecast to reach a readjusted size of US$ 33320 million by 2032 with a CAGR of 8.2% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 92
USD 4250.00
(Single User License)
Preclinical Contract Research Organization (CRO) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Preclinical Contract Research Organization (CRO) was estimated to be worth US$ 19380 million in 2025 and is projected to reach US$ 33320 million, growing at a CAGR of 8.2% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 107
USD 3950.00
(Single User License)
Global Preclinical Contract Research Organization (CRO) Market Research Report 2026
The global Preclinical Contract Research Organization (CRO) market was valued at US$ 19380 million in 2025 and is anticipated to reach US$ 33320 million by 2032, at a CAGR of 8.2% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 118
USD 2900.00
(Single User License)
Global Preclinical Contract Research Organization (CRO) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Preclinical Contract Research Organization (CRO) market size was US$ 17780 million in 2024 and is forecast to a readjusted size of US$ 31040 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.
Published Date: 2025-11-16
Pages: 92
USD 4250.00
(Single User License)
Preclinical Contract Research Organization (CRO) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Preclinical Contract Research Organization (CRO) was estimated to be worth US$ 17780 million in 2024 and is forecast to a readjusted size of US$ 31040 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.
Published Date: 2025-06-01
Pages: 107
USD 3950.00
(Single User License)
Global Preclinical Contract Research Organization (CRO) Market Insights, Forecast to 2031
The global Preclinical Contract Research Organization (CRO) market is projected to grow from US$ 19380 million in 2025 to US$ 31040 million by 2031, at a Compound Annual Growth Rate (CAGR) of 8.2% during the forecast period.
Published Date: 2025-06-01
Pages: 138
USD 4900.00
(Single User License)
Global Preclinical Contract Research Organization (CRO) Market Research Report 2025
The global market for Preclinical Contract Research Organization (CRO) was valued at US$ 17780 million in the year 2024 and is projected to reach a revised size of US$ 31040 million by 2031, growing at a CAGR of 8.2% during the forecast period.
Published Date: 2025-06-01
Pages: 90
USD 2900.00
(Single User License)
Global Preclinical Contract Research Organization (CRO) Market Insights, Forecast to 2030
A preclinical CRO (contract research organizations) helps new medical product developers (including devices, drugs, biologics and more) prove those products are safe and effective in live models the FDA deems approximate as closely as possible the human anatomy prior to those devices enter clinical trials (or receiving other approvals like 510Ks) or use for human care.
Published Date: 2024-04-12
Pages: 106
USD 4900.00
(Single User License)
Global Preclinical Contract Research Organization (CRO) Market Research Report 2024
A preclinical CRO (contract research organizations) helps new medical product developers (including devices, drugs, biologics and more) prove those products are safe and effective in live models the FDA deems approximate as closely as possible the human anatomy prior to those devices enter clinical trials (or receiving other approvals like 510Ks) or use for human care.
Published Date: 2024-01-12
Pages: 82
USD 2900.00
(Single User License)
Preclinical Contract Research Organization (CRO) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A preclinical CRO (contract research organizations) helps new medical product developers (including devices, drugs, biologics and more) prove those products are safe and effective in live models the FDA deems approximate as closely as possible the human anatomy prior to those devices enter clinical trials (or receiving other approvals like 510Ks) or use for human care.
Published Date: 2024-01-08
Pages: 109
USD 3950.00
(Single User License)

Global Preclinical Contract Research Organization (CRO) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Preclinical Contract Research Organization (CRO) market size was US$ 19380 million in 2025 and is forecast to reach a readjusted size of US$ 33320 million by 2032 with a CAGR of 8.2% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 92
USD 4250.00 (Single User License)
Preclinical Contract Research Organization (CRO) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Preclinical Contract Research Organization (CRO) was estimated to be worth US$ 19380 million in 2025 and is projected to reach US$ 33320 million, growing at a CAGR of 8.2% from 2026 to 2032.
Published: 2026-03-06
Pages: 107
USD 3950.00 (Single User License)
Global Preclinical Contract Research Organization (CRO) Market Research Report 2026
The global Preclinical Contract Research Organization (CRO) market was valued at US$ 19380 million in 2025 and is anticipated to reach US$ 33320 million by 2032, at a CAGR of 8.2% from 2026 to 2032.
Published: 2026-03-06
Pages: 118
USD 2900.00 (Single User License)
Global Preclinical Contract Research Organization (CRO) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Preclinical Contract Research Organization (CRO) market size was US$ 17780 million in 2024 and is forecast to a readjusted size of US$ 31040 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.
Published: 2025-11-16
Pages: 92
USD 4250.00 (Single User License)
Preclinical Contract Research Organization (CRO) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Preclinical Contract Research Organization (CRO) was estimated to be worth US$ 17780 million in 2024 and is forecast to a readjusted size of US$ 31040 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.
Published: 2025-06-01
Pages: 107
USD 3950.00 (Single User License)
Global Preclinical Contract Research Organization (CRO) Market Insights, Forecast to 2031
The global Preclinical Contract Research Organization (CRO) market is projected to grow from US$ 19380 million in 2025 to US$ 31040 million by 2031, at a Compound Annual Growth Rate (CAGR) of 8.2% during the forecast period.
Published: 2025-06-01
Pages: 138
USD 4900.00 (Single User License)
Global Preclinical Contract Research Organization (CRO) Market Research Report 2025
The global market for Preclinical Contract Research Organization (CRO) was valued at US$ 17780 million in the year 2024 and is projected to reach a revised size of US$ 31040 million by 2031, growing at a CAGR of 8.2% during the forecast period.
Published: 2025-06-01
Pages: 90
USD 2900.00 (Single User License)
Global Preclinical Contract Research Organization (CRO) Market Insights, Forecast to 2030
A preclinical CRO (contract research organizations) helps new medical product developers (including devices, drugs, biologics and more) prove those products are safe and effective in live models the FDA deems approximate as closely as possible the human anatomy prior to those devices enter clinical trials (or receiving other approvals like 510Ks) or use for human care.
Published: 2024-04-12
Pages: 106
USD 4900.00 (Single User License)
Global Preclinical Contract Research Organization (CRO) Market Research Report 2024
A preclinical CRO (contract research organizations) helps new medical product developers (including devices, drugs, biologics and more) prove those products are safe and effective in live models the FDA deems approximate as closely as possible the human anatomy prior to those devices enter clinical trials (or receiving other approvals like 510Ks) or use for human care.
Published: 2024-01-12
Pages: 82
USD 2900.00 (Single User License)
Preclinical Contract Research Organization (CRO) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A preclinical CRO (contract research organizations) helps new medical product developers (including devices, drugs, biologics and more) prove those products are safe and effective in live models the FDA deems approximate as closely as possible the human anatomy prior to those devices enter clinical trials (or receiving other approvals like 510Ks) or use for human care.
Published: 2024-01-08
Pages: 109
USD 3950.00 (Single User License)